MedPath

M.D. ANDERSON CANCER CENTER

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases

Phase 2
Completed
Conditions
Breast Cancer
Bone Metastases
Interventions
Drug: 153 Sm-EDTMP
Behavioral: Questionnaire
Procedure: Stem Cell Transplant
First Posted Date
2007-01-31
Last Posted Date
2015-11-24
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
12
Registration Number
NCT00429507
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Metastatic Breast Carcinoma
Invasive Breast Carcinoma
Interventions
First Posted Date
2007-01-31
Last Posted Date
2013-04-10
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
32
Registration Number
NCT00429182
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

Gemcitabine and Dasatinib in Advanced Solid Tumors

Phase 1
Completed
Conditions
Advanced Cancer
Solid Tumors
Interventions
First Posted Date
2007-01-31
Last Posted Date
2013-04-04
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
54
Registration Number
NCT00429234
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients

Phase 2
Completed
Conditions
Amenorrhea
Premature Ovarian Failure
Ovarian Function Insufficiency
Interventions
Drug: Leuprolide Acetate
Behavioral: Questionnaire
Procedure: Hematopoietic Stem Cell Transplantation
First Posted Date
2007-01-31
Last Posted Date
2013-07-09
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
60
Registration Number
NCT00429494
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

Herceptin and GM-CSF for Metastatic Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2007-01-31
Last Posted Date
2012-12-06
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
18
Registration Number
NCT00429104
Locations
🇺🇸

U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Drug: Fludarabine
Drug: Melphalan
Procedure: Stem Cell Infusion
First Posted Date
2007-01-31
Last Posted Date
2012-08-07
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
19
Registration Number
NCT00429572
Locations
🇺🇸

U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Survey of the Need for Information on Fertility and Menopause-Related Treatment Effects Among HSCT Patients

Completed
Conditions
Stem Cell Transplantation
Interventions
Behavioral: Survey
First Posted Date
2007-01-31
Last Posted Date
2012-08-01
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
196
Registration Number
NCT00429455
Locations
🇺🇸

U.T. M.D. Anderson Cancer Center, Houston, Texas, United States

3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate

Not Applicable
Terminated
Conditions
Prostate Cancer
Interventions
Procedure: AIR-MRSI
Procedure: PFC-MRSI
First Posted Date
2007-01-31
Last Posted Date
2015-01-09
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
8
Registration Number
NCT00429338
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer

Phase 3
Terminated
Conditions
Breast Cancer
Interventions
First Posted Date
2007-01-31
Last Posted Date
2016-05-09
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
1
Registration Number
NCT00429403
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

🇯🇵

St. Luke's International Hospital, Tokyo, Japan

Interest in Spirituality and Oncology: Is It An International Phenomenon?

Withdrawn
Conditions
Stress
Interventions
Behavioral: Survey
First Posted Date
2007-01-31
Last Posted Date
2011-11-18
Lead Sponsor
M.D. Anderson Cancer Center
Registration Number
NCT00429117
© Copyright 2025. All Rights Reserved by MedPath